SORT BY

FILTER BY

also on other fortune lists

company facts

f500 stats

Fortune 500

708

Illumina

ILMN

Looking for leads, investment insights, or competitive intelligence?

CEO

Francis A. deSouza

CEO Title

President, Chief Executive Officer & Director

Sector

Technology

Industry

Scientific,Photographic and Control Equipment

HQ Location

San Diego, Calif.

Years on Fortune 500 List

-

Employees

7,300

Key Financials (Last Fiscal Year)
$ millions% change
Revenues ($M)$3,33321.1%
Profits ($M)$826.013.8%
Assets ($M)$6,959
Total Stockholder Equity ($M)$3,758
Profit Ratios
Profit as % of Revenues24.8%
Profits as % of Assets11.9%
Profits as % of Stockholder Equity22.0%
Earnings Per Share (Last Fiscal Year)
Earnings Per Share ($)5.56
EPS % Change (from 2017)13.0%
EPS % Change (5 year annual rate)43.9%
EPS % Change (10 year annual rate)30.8%
Total Return
Total Return to Investors (2018)37.3%
Total Return to Investors (5 year, annualized)22.1%
Total Return to Investors (10 year, annualized)27.7%
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Illumina

Commentary: Attacking Biology’s Complexity with New Genomics Approaches

An Illumina co-founder and Venrock's Bryan Roberts weigh in.

Read More →
The 5 Best Biotech and Health Care Stocks to Buy for 2019 Now That Congress Can’t Repeal Obamacare

With Congress split between Republicans and Democrats, pharma and biotech stocks are ready to surge.

Read More →
These Are the Health Care Companies Poised for Explosive Growth

From genetic testing giants to copycat drug manufacturers, here are the global companies set to make a mark on medicine.

Read More →